HLF (gene): Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m Bot: HTTP→HTTPS |
||
Line 1: | Line 1: | ||
{{DISPLAYTITLE:''HLF'' (gene)}} | |||
{{ | {{Infobox_gene}} | ||
| | '''Hepatic leukemia factor''' is a [[protein]] that in humans is encoded by the ''HLF'' [[gene]].<ref name="pmid1386162">{{cite journal | vauthors = Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT | title = Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia | journal = Science | volume = 257 | issue = 5069 | pages = 531–4 | date = July 1992 | pmid = 1386162 | pmc = | doi = 10.1126/science.1386162 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: HLF hepatic leukemia factor| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3131| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
}} | |||
== Function == | |||
This gene encodes a member of the [[proline]] and [[acid]]ic-rich (PAR) protein family, a subset of the bZIP transcription factors. The encoded protein forms homodimers or heterodimers with other PAR family members and binds sequence-specific promoter elements to activate transcription. Chromosomal translocations fusing portions of this gene with the E2A gene cause a subset of childhood B-lineage acute lymphoid leukemias. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.<ref name="entrez">{{cite web | title = Entrez Gene: HLF hepatic leukemia factor| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3131| accessdate = }}</ref> | |||
==References== | == References == | ||
{{reflist | {{reflist}} | ||
==Further reading== | |||
== Further reading == | |||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = LeBrun DP | title = E2A basic helix-loop-helix transcription factors in human leukemia | journal = Frontiers in Bioscience | volume = 8 | issue = | pages = s206-22 | date = May 2003 | pmid = 12700034 | doi = 10.2741/1030 }} | |||
* {{cite journal | vauthors = Hunger SP, Ohyashiki K, Toyama K, Cleary ML | title = Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia | journal = Genes & Development | volume = 6 | issue = 9 | pages = 1608–20 | date = September 1992 | pmid = 1516826 | doi = 10.1101/gad.6.9.1608 }} | |||
*{{cite journal | * {{cite journal | vauthors = Falvey E, Fleury-Olela F, Schibler U | title = The rat hepatic leukemia factor (HLF) gene encodes two transcriptional activators with distinct circadian rhythms, tissue distributions and target preferences | journal = The EMBO Journal | volume = 14 | issue = 17 | pages = 4307–17 | date = September 1995 | pmid = 7556072 | pmc = 394515 | doi = }} | ||
* {{cite journal | vauthors = Hunger SP, Brown R, Cleary ML | title = DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF | journal = Molecular and Cellular Biology | volume = 14 | issue = 9 | pages = 5986–96 | date = September 1994 | pmid = 8065331 | pmc = 359124 | doi = 10.1128/mcb.14.9.5986 }} | |||
*{{cite journal | * {{cite journal | vauthors = Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT | title = DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein | journal = Molecular and Cellular Biology | volume = 14 | issue = 5 | pages = 3403–13 | date = May 1994 | pmid = 8164688 | pmc = 358705 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Hunger SP | title = Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis | journal = Blood | volume = 87 | issue = 4 | pages = 1211–24 | date = February 1996 | pmid = 8608207 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA | title = A "double adaptor" method for improved shotgun library construction | journal = Analytical Biochemistry | volume = 236 | issue = 1 | pages = 107–13 | date = April 1996 | pmid = 8619474 | doi = 10.1006/abio.1996.0138 }} | ||
*{{cite journal | * {{cite journal | vauthors = Hunger SP, Li S, Fall MZ, Naumovski L, Cleary ML | title = The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties | journal = Blood | volume = 87 | issue = 11 | pages = 4607–17 | date = June 1996 | pmid = 8639829 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA | title = Large-scale concatenation cDNA sequencing | journal = Genome Research | volume = 7 | issue = 4 | pages = 353–8 | date = April 1997 | pmid = 9110174 | pmc = 139146 | doi = 10.1101/gr.7.4.353 }} | ||
*{{cite journal | * {{cite journal | vauthors = Takahata S, Sogawa K, Kobayashi A, Ema M, Mimura J, Ozaki N, Fujii-Kuriyama Y | title = Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock | journal = Biochemical and Biophysical Research Communications | volume = 248 | issue = 3 | pages = 789–94 | date = July 1998 | pmid = 9704006 | doi = 10.1006/bbrc.1998.9012 }} | ||
*{{cite journal | * {{cite journal | vauthors = Inukai T, Inaba T, Ikushima S, Look AT | title = The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF | journal = Molecular and Cellular Biology | volume = 18 | issue = 10 | pages = 6035–43 | date = October 1998 | pmid = 9742120 | pmc = 109189 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Begbie M, Mueller C, Lillicrap D | title = Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes | journal = DNA and Cell Biology | volume = 18 | issue = 2 | pages = 165–73 | date = February 1999 | pmid = 10073576 | doi = 10.1089/104454999315556 }} | ||
* {{cite journal | vauthors = Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, Fujii-Kuriyama Y | title = Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300 | journal = The EMBO Journal | volume = 18 | issue = 7 | pages = 1905–14 | date = April 1999 | pmid = 10202154 | pmc = 1171276 | doi = 10.1093/emboj/18.7.1905 }} | |||
*{{cite journal | * {{cite journal | vauthors = Honda H, Inaba T, Suzuki T, Oda H, Ebihara Y, Tsuiji K, Nakahata T, Ishikawa T, Yazaki Y, Hirai H | title = Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia | journal = Blood | volume = 93 | issue = 9 | pages = 2780–90 | date = May 1999 | pmid = 10216071 | doi = }} | ||
*{{cite journal | * {{cite journal | vauthors = Matsunaga T, Inaba T, Matsui H, Okuya M, Miyajima A, Inukai T, Funabiki T, Endo M, Look AT, Kurosawa H | title = Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein | journal = Blood | volume = 103 | issue = 8 | pages = 3185–91 | date = April 2004 | pmid = 15070701 | doi = 10.1182/blood-2003-09-3022 }} | ||
*{{cite journal | |||
*{{cite journal | |||
*{{cite journal | |||
*{{cite journal | |||
}} | |||
{{refend}} | {{refend}} | ||
Line 87: | Line 32: | ||
* {{MeshName|HLF+protein,+human}} | * {{MeshName|HLF+protein,+human}} | ||
{{NLM content}} | |||
{{Transcription factors|g1}} | |||
[[Category:Transcription factors]] | [[Category:Transcription factors]] | ||
{{ | |||
{{gene-17-stub}} |
Latest revision as of 13:52, 31 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Hepatic leukemia factor is a protein that in humans is encoded by the HLF gene.[1][2]
Function
This gene encodes a member of the proline and acidic-rich (PAR) protein family, a subset of the bZIP transcription factors. The encoded protein forms homodimers or heterodimers with other PAR family members and binds sequence-specific promoter elements to activate transcription. Chromosomal translocations fusing portions of this gene with the E2A gene cause a subset of childhood B-lineage acute lymphoid leukemias. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.[2]
References
- ↑ Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT (July 1992). "Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia". Science. 257 (5069): 531–4. doi:10.1126/science.1386162. PMID 1386162.
- ↑ 2.0 2.1 "Entrez Gene: HLF hepatic leukemia factor".
Further reading
- LeBrun DP (May 2003). "E2A basic helix-loop-helix transcription factors in human leukemia". Frontiers in Bioscience. 8: s206–22. doi:10.2741/1030. PMID 12700034.
- Hunger SP, Ohyashiki K, Toyama K, Cleary ML (September 1992). "Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia". Genes & Development. 6 (9): 1608–20. doi:10.1101/gad.6.9.1608. PMID 1516826.
- Falvey E, Fleury-Olela F, Schibler U (September 1995). "The rat hepatic leukemia factor (HLF) gene encodes two transcriptional activators with distinct circadian rhythms, tissue distributions and target preferences". The EMBO Journal. 14 (17): 4307–17. PMC 394515. PMID 7556072.
- Hunger SP, Brown R, Cleary ML (September 1994). "DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF". Molecular and Cellular Biology. 14 (9): 5986–96. doi:10.1128/mcb.14.9.5986. PMC 359124. PMID 8065331.
- Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT (May 1994). "DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein". Molecular and Cellular Biology. 14 (5): 3403–13. PMC 358705. PMID 8164688.
- Hunger SP (February 1996). "Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis". Blood. 87 (4): 1211–24. PMID 8608207.
- Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA (April 1996). "A "double adaptor" method for improved shotgun library construction". Analytical Biochemistry. 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID 8619474.
- Hunger SP, Li S, Fall MZ, Naumovski L, Cleary ML (June 1996). "The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties". Blood. 87 (11): 4607–17. PMID 8639829.
- Yu W, Andersson B, Worley KC, Muzny DM, Ding Y, Liu W, Ricafrente JY, Wentland MA, Lennon G, Gibbs RA (April 1997). "Large-scale concatenation cDNA sequencing". Genome Research. 7 (4): 353–8. doi:10.1101/gr.7.4.353. PMC 139146. PMID 9110174.
- Takahata S, Sogawa K, Kobayashi A, Ema M, Mimura J, Ozaki N, Fujii-Kuriyama Y (July 1998). "Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock". Biochemical and Biophysical Research Communications. 248 (3): 789–94. doi:10.1006/bbrc.1998.9012. PMID 9704006.
- Inukai T, Inaba T, Ikushima S, Look AT (October 1998). "The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF". Molecular and Cellular Biology. 18 (10): 6035–43. PMC 109189. PMID 9742120.
- Begbie M, Mueller C, Lillicrap D (February 1999). "Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes". DNA and Cell Biology. 18 (2): 165–73. doi:10.1089/104454999315556. PMID 10073576.
- Ema M, Hirota K, Mimura J, Abe H, Yodoi J, Sogawa K, Poellinger L, Fujii-Kuriyama Y (April 1999). "Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300". The EMBO Journal. 18 (7): 1905–14. doi:10.1093/emboj/18.7.1905. PMC 1171276. PMID 10202154.
- Honda H, Inaba T, Suzuki T, Oda H, Ebihara Y, Tsuiji K, Nakahata T, Ishikawa T, Yazaki Y, Hirai H (May 1999). "Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia". Blood. 93 (9): 2780–90. PMID 10216071.
- Matsunaga T, Inaba T, Matsui H, Okuya M, Miyajima A, Inukai T, Funabiki T, Endo M, Look AT, Kurosawa H (April 2004). "Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein". Blood. 103 (8): 3185–91. doi:10.1182/blood-2003-09-3022. PMID 15070701.
External links
- HLF+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
![]() | This article on a gene on human chromosome 17 is a stub. You can help Wikipedia by expanding it. |